¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"age"¿¡ ´ëÇÑ Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú :
5
ÆäÀÌÁö:
3
ÄÚµå
¿µ¹®
ÇѱÛ
Y55
Agents primarily acting on smooth and skeletal muscles and the respiratory system
ÀÏÂ÷ÀûÀ¸·Î ÆòȰ±Ù ¹× °ñ°Ý±Ù°ú È£Èí±â°èÅë¿¡ ÀÛ¿ëÇÏ´Â ¾àÁ¦
Y44
Agents primarily affecting blood constituents
ÀÏÂ÷ÀûÀ¸·Î Ç÷¾×¼ººÐ¿¡ ÀÛ¿ëÇÏ´Â ¾àÁ¦
Y56
Agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs
ÀÏÂ÷ÀûÀ¸·Î ÇǺΠ¹× Á¡¸·¿¡ ÀÛ¿ëÇÏ´Â ¾àÁ¦¿Í ¾È°úÀû, À̺ñÀÎÈİúÀû ¹× Ä¡°úÀû ¾àÁ¦
Y52
Agents primarily affecting the cardiovascular system
ÀÏÂ÷ÀûÀ¸·Î ½ÉÀåÇ÷°ü°èÅë¿¡ ÀÛ¿ëÇÏ´Â ¾àÁ¦
Y53
Agents primarily affecting the gastrointestinal system
ÀÏÂ÷ÀûÀ¸·Î À§Ã¢ÀÚ°èÅë¿¡ ÀÛ¿ëÇÏ´Â ¾àÁ¦
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
ÄÚµå
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½